Concepedia

Publication | Open Access

Safety and tolerability of conditioning chemotherapy followed by CD19-targeted CAR T cells for relapsed/refractory CLL

98

Citations

53

References

2019

Year

Abstract

Juno Therapeutics.

References

YearCitations

Page 1